Pharmaceutical competitive intelligence teams face unique challenges in today’s market. Given the economy’s turbulence since 2008, many companies have cut their CI teams entirely. But the study shows that organizations that retained their competitive intelligence groups through the tough times are gradually increasing resources for CI. Furthermore, they’re elevating these teams’ strategic positioning to deliver maximum impact.
The report “Strategic Pharmaceutical Competitive Intelligence: Trends and Implications for the Future ” by Cutting Edge Information includes benchmarks that detail competitive intelligence teams’ structure, reporting lines, budgets and staffing metrics. Other metrics explore team responsibilities, additional support from other functions and performance measurement methodologies.
No comments:
Post a Comment